Order results by:
| Issue | Title | |
| Vol 6, No 5 (2010) | LONG-TERM THERAPY WITH ACETYLSALICYLIC ACID. HOW TO AVOID THE POSSIBLE COMPLICATIONS? | Abstract similar documents |
| I. V. Zhirov | ||
| "... Data about efficacy and safety of long-term therapy with acetylsalicylic acid in patients ..." | ||
| Vol 9, No 4 (2013) | ACETYLSALICYLIC ACID: CONTROVERSIAL AND OUTSTANDING ISSUES | Abstract similar documents |
| E. N. Dankovtseva | ||
| "... Review of current ideas about the role of acetylsalicylic acid (ASA) in the primary prevention ..." | ||
| Vol 7, No 4 (2011) | ON THE 125TH ANNIVERSARY OF ACETYLSALICYLIC ACID | Abstract similar documents |
| I. N. Bokarev, L. V. Popova | ||
| "... An experience of acetylsalicylic acid (ASA) clinical use since its synthesis in 1887 ..." | ||
| Vol 8, No 2 (2012) | ACETYLSALICYLIC ACID IN THE PREVENTION OF ATHEROTHROMBOTIC EVENTS | Abstract similar documents |
| A. V. Govorin, A. P. Filev | ||
| "... of acetylsalicylic acid (ASA) in primary and secondary prevention of atherothrombotic events. Studies on the safety ..." | ||
| Vol 5, No 4 (2009) | GASTROENTEROPATHIES ASSOCIATED WITH ACETYLSALICYLIC ACID: HOW TO IMPROVE SAFETY OF THERAPY | Abstract similar documents |
| A. L. Komarov | ||
| "... Lesion of gastrointestinal mucous coat is the main factor limited acetylsalicylic acid (ASA) use ..." | ||
| Vol 8, No 4 (2012) | ACETYLSALICYLIC ACID: WHAT'S NEW IN THE OLD DRUG? | Abstract similar documents |
| I. V. Zhirov | ||
| "... The results of recent trials on acetylsalicylic acid (ASA) efficacy are presented. Data ..." | ||
| Vol 5, No 6 (2009) | ACETYLSALICYLIC ACID IN LOW DOSES FOR SECONDARY PREVENTION OF CARDIO-VASCULAR COMPLICATIONS | Abstract similar documents |
| N. A. Dmitrieva, S. N. Tolpygina | ||
| "... Data of evidence based medicine which confirm efficacy of acetylsalicylic acid (ACA ..." | ||
| Vol 18, No 1 (2022) | Cerebrovascular Accident in a Patient with Polycythemia: a Case Report | Abstract similar documents |
| O. M. Drapkina, I. I. Almazova, A. V. Smirnova, S. A. Berns, R. N. Shepel | ||
| "... своевременного установления диагноза и индивидуального, патогенетически обоснованного подбора длительной ..." | ||
| Vol 13, No 2 (2017) | RIVAROXABAN HAS DEMONSTRATED AN ADVANTAGE OVER ACETYLSALICYLIC ACID IN PREVENTING THE RECURRENCE OF VENOUS THROMBOEMBOLIC EVENTS IN THE EINSTEIN CHOICE STUDY | Abstract similar documents |
| . Editorial | ||
| "... эффективность и безопасность ривароксабана в дозах 20 мг 1 р/д*, 10 мг 1 р/д и ацетилсалициловой кислоты в дозе ..." | ||
| Vol 3, No 3 (2007) | RESISTANCE TO ANTIPLATELET DRUGS IN PATIENTS WITH ISCHEMIC HEART DISEASE | Abstract similar documents |
| D. H. Aynetdinova, A. E. Udovichenko, V. A. Sulimov | ||
| Vol 8, No 5 (2012) | ACETYLSALICYLIC ACID: DO WE KNOW EVERYTHING ABOUT IT AND ITS PROPER USE? | Abstract similar documents |
| S. A. Boldueva, I. A. Leonova | ||
| "... Use of acetylsalicylic acid (ASA) in cardiology practice is presented. ASA modes of action ..." | ||
| Vol 3, No 4 (2007) | RESISTANCE TO ACETYLSALICYLIC ACID AND PREVALENCE OF THROMBOSIS IN PATIENTS WITH STABLE ANGINA | Abstract similar documents |
| N. F. Putchinyan, N. V. Furman, P. Ya. Dovgalevskyi | ||
| "... sensitivity to acetylsalicylic acids (ASA) in patients with stable angina. Material and methods. 96 patients ..." | ||
| Vol 8, No 2 (2012) | EFFICACY AND SAFETY OF ACETYLSALICYLIC ACID IN PRIMARY AND SECONDARY PREVENTION OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| S. N. Tolpygina, S. Yu. Martsevich, E. N. Khoseva, N. V. Kiseleva | ||
| "... Acetylsalicylic acid (ASA) use in the primary and secondary prevention of cardiovascular diseases ..." | ||
| Vol 4, No 1 (2008) | COMPARISON OF ANTIPLATELET EFFECT AND SAFETY OF ORIGINAL DRUG «ASPIRIN CARDIO» AND GENERIC«ACECARDOL» IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE | Abstract similar documents |
| N. A. Belolipetskiy, S. N. Tolpygina, O. А. Litinskaya, V. G. Belolipetskaya, S. Yu. Martsevich | ||
| "... Aim. To compare antiplatelet effect of two acetylsalicylic acid medicines, Acecardol ("Synthesis ..." | ||
| Vol 12, No 4 (2016) | High residual platelet reactivity during dual antiplatelet therapy, found by optical aggregometry and the rate of atherothrombotic complications after coronary artery stenting in patients with ischemic heart disease in clinical practice | Abstract similar documents |
| N. F. Puchinyan, N. V. Furman, P. V. Dolotovskaya, L. L. Malinova | ||
| "... antiplatelet therapy (DAT) with acetylsalicylic acid (ASA) and clopidogrel by optical aggregometry in patients ..." | ||
| Vol 12, No 5 (2016) | Features of the Hemostasis and Platelets Enzyme Activity in Patients with Different Sensitivity to Acetylsalicylic Acid by the Acute Coronary Syndrome | Abstract similar documents |
| I. Yu. Grinshtein, A. A. Savchenko, Yu. I. Grinshtein, M. M. Petrova | ||
| "... in acetylsalicylic acid (ASA) sensitive and resistant patients with acute coronary syndrome (ACS). Material ..." | ||
| Vol 7, No 2 (2011) | PECULIAR PROPERTIES OF ANTITHROMBOTIC THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION. IS IT POSSIBLE TO DO THE TREATMENT SAFE? | Abstract similar documents |
| I. V. Zotova, D. A. Zateyshchikov | ||
| Vol 6, No 6 (2010) | COMPARISON OF ANTIPLATELET EFFICACY OF ORIGINAL AND GENERIC ENTEROSOLUBLE ACETYLSALICYLIC ACID IN PATIENTS WITH HIGH CARDIOVASCULAR RISK. SIMPLE BLIND CROSSED RANDOMIZED CONTROLLED STUDY (IKAR) | Abstract similar documents |
| S. Yu. Martsevich, S. N. Tolpygina, E. S. Boychenko, R. E. Dubinskaya, Yu. V. Lukina, V. P. Voronina | ||
| "... acetylsalicylic acid (ASA) in patients with high cardiovascular risk. Material and мethods. Patients (n=30 ..." | ||
| Vol 8, No 2 (2012) | RESIDUAL PLATELET REACTIVITY DURING THERAPY WITH INHIBITORS OF CYCLOOXIGENASE OR ADENOSINE DIPHOSPHATE RECEPTORS | Abstract similar documents |
| A. A. Lomonosova, N. A. Mazur, E. A. Zolozova, E. V. Sayutina, V. V. Chigineva, N. V. Shestakova | ||
| "... Aim. To compare effects of acetylsalicylic acid (ASA) and two clopidogrel drugs on residual ..." | ||
| Vol 17, No 1 (2021) | Aspirin Resistance as a Result of Impaired Interaction of Platelets and Neutrophils in Patients with Coronary Heart Disease | Abstract similar documents |
| M. D. Goncharov, A. A. Savchenko, Yu. I. Grinshtein, I. I. Gvozdev, A. A. Kosinova, T. S. Mongush | ||
| "... bypass grafting (CABG), depending on sensitivity to acetylsalicylic acid (ASA). Material and methods ..." | ||
| Vol 5, No 5 (2009) | EFFECTS OF ACETYLSALICYLIC ACID AND CLOPIDOGREL ON MORPHOFUNCTIONAL STATUS OF ERYTHROCYTES IN PATIENTS WITH ACUTE CORONARY SYNDROME | Abstract similar documents |
| A. L. Alyavi, R. A. Rakhimov, B. A. Alyavi | ||
| "... and combined antiplatelet therapy (acetylsalicylic acid and clopidogrel). Material and methods. 98 patients ..." | ||
| Vol 6, No 2 (2010) | EFFICACY AND SAFETY OF ACIDUM ACETYLSALICYLICUM USAGE | Abstract similar documents |
| V. N. Drozdov, V. A. Kim | ||
| "... Data about efficacy and safety of acetylsalicylic acid usage as antiplatelet drug and for cancer ..." | ||
| Vol 5, No 3 (2009) | ANTIPLATELET DRUGS RESISTANCE IN PATIENTS WITH ISCHEMIC HEART DISEASE AND OBLITERATIVE ATHEROSCLEROSIS OF LOWER LIMB ARTERIES ASSOCIATED WITH DIABETES MELLITUS TYPE 2 | Abstract similar documents |
| E. V. Gorjacheva, A. E. Udovichenko, V. A. Sulimov, N. V. Lavrishcheva, M. A. Surikova, T. N. Gracheva | ||
| "... Aim. To study a rate of resistance to acetylsalicylic acid (ASA) and clopidogrel and clinical ..." | ||
| Vol 4, No 2 (2008) | ANTIPLATELET THERAPY RESISTANCE IN PATIENTS WITH ACUTE CORONARY SYNDROME WITH ST-SEGMENT ELEVATION | Abstract similar documents |
| D. H. Ainetdinova, A. Е. Udovichenko, V. A. Sulimov | ||
| "... Aim. To evaluate the incidence of acetylsalicylic acid (ASA) and clopidogrel resistance ..." | ||
| Vol 14, No 3 (2018) | THE POSSIBILITIES OF USING A NEW FIXED-DOSE COMBINATION OF ROSUVASTATIN AND ACETYLSALICYLIC ACID: FOCUS GROUPS OF PATIENTS | Abstract similar documents |
| O. D. Ostroumova, A. I. Kochetkov, N. Yu. Voevodina, S. S. Sharonova | ||
| "... are presented. Current data on the pattern of antiplatelet use, including acetylsalicylic acid, in individuals ..." | ||
| Vol 5, No 6 (2009) | RISK OF REPEATED THROMBOTIC EVENTS IN PATIENTS SURVIVED ACUTE CORONARY SYNDROME AND HAVING LABORATORY PROVEN RESISTANCE TO ACETYLSALICYLIC ACID | Abstract similar documents |
| N. F. Puchinyan, N. V. Furman, A. R. Kiselev, Ya. P. Dovgalevsky | ||
| "... to acetylsalicylic acid (ASA) therapy. Material and methods. 200 patients with ACS (aged 56,6±9,2 y.o.) were ..." | ||
| Vol 17, No 4 (2021) | Monitoring of Aspirin Therapy in Patients with Cerebrovascular Pathology | Abstract similar documents |
| M. M. Tanashyan, A. A. Raskurazhev, A. A. Kornilova, A. A. Shabalina, D. A. Abaimov, A. V. Naminov | ||
| "... manifestations of CVD. All patients received acetylsalicylic acid (ASA) 75 mg daily. Along with a comprehensive ..." | ||
| Vol 10, No 3 (2014) | COST-EFFECTIVENESS OF APIXABAN AS COMPARED WITH WARFARIN AND ACETYLSALICYLIC ACID IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN THE RUSSIAN FEDERATION | Abstract similar documents |
| A. V. Rudakova, V. A. Parfenov | ||
| "... K antagonists (such as warfarin), antiplatelet therapy (such as acetylsalicylic acid) and novel oral ..." | ||
| Vol 12, No 3 (2016) | CLINICAL AND LABORATORY CHARACTERISTICS OF PATIENTS WITH ISCHEMIC HEART DISEASE RESISTANT TO ACETYLSALICYLIC ACID IN PERIOPERATIVE PERIOD OF CORONARY ARTERY BYPASS GRAFT: RESULTS OF AN OPEN PROSPECTIVE STUDY | Abstract PDF (Eng) similar documents |
| Yu. I. Grinshtein, A. A. Kosinova, I. Yu. Grinshtein, A. V. Kovalev, V. G. Sukhovol'skiy, A. A. Savchenko | ||
| "... that are sensitive or resistant to acetylsalicylic acid (ASA) before and after coronary artery bypass graft (CABG ..." | ||
| Vol 20, No 6 (2024) | Platelet reactivity clinical and biochemical markers when taking acetylsalicylic acid as part of dual antiplatelet therapy in the myocardial infarction subacute period | Abstract similar documents |
| T. P. Pronko, V. A. Snezhitskiy, A. V. Kapytski | ||
| "... of myocardial infarction (MI) during the administration of acetylsalicylic acid (ASA) as part of dual ..." | ||
| Vol 15, No 3 (2019) | Study of the Association of V640L (rs6133) Polymorphism in the Platelet P-selectin Gene with Acetylsalicylic Acid Resistance in Patients after Coronary Bypass Surgery | Abstract similar documents |
| A. A. Kosinova, T. S. Mongush, M. D. Goncharov, T. N. Subbotina, K. S. Semashchenko, G. Y. Kochmareva, Yu. I. Grinshtein | ||
| "... with acetylsalicylic acid (ASA) resistance in patients with coronary heart disease after coronary bypass surgery (CABG ..." | ||
| Vol 18, No 3 (2022) | Study the Association of Nucleotide Polymorphisms in Platelet Receptor and Cytochrome P450 Genes with the Development of Resistance to Antiplatelet Drugs in Patients with Coronary Artery Disease | Abstract similar documents |
| K. S. Semashchenko, T. S. Mongush, A. A. Kosinova, T. N. Subbotina, Y. I. Grinshtein | ||
| "... 140 patients in the acetylsalicylic acid (ASA) treatment group and 103 patients in the dual ..." | ||
| Vol 16, No 3 (2020) | A Prospective, Initiative, Single-Center Open Post-Registration Comparative Study of Laboratory Efficacy of Various Forms of Acetylsalicylic Acid in a Cardioprotective Dose with Different Composition of Excipients: Results of the SFAIROS Study | Abstract similar documents |
| N. V. Lomakin, L. I. Buryachkovskaya, D. A. Zolin, V. I. Kazey | ||
| "... and pharmacokinetic parameters of branded generic preparations of acetylsalicylic acid (ASA) in buffered form ..." | ||
| Vol 2, No 3 (2006) | ANTITHROMBOTIC THERAPY OF ISCHEMIC HEART DISEASE: FROM FAST ACTING ANTIAGGREGANTS TO STATINES AND NITRATE OXIDE. IS IT REAL? | Abstract similar documents |
| I. A. Latfullin, A. A. Podolskaya | ||
| "... of action and clinical efficiency of antithrombotic and antiplatelet medicines such as acetylsalicylic acid ..." | ||
| Vol 15, No 3 (2019) | Treatment of Patients with Stable Manifestations of Atherosclerosis: New Opportunities | Abstract similar documents |
| article Editorial | ||
| "... and acetylsalicylic acid can be recommended after registration of the indication for almost all patients ..." | ||
| Vol 10, No 5 (2014) | DUAL ANTIPLATELET THERAPY IN THE REAL CLINICAL PRACTICE | Abstract similar documents |
| G. N. Guseva, T. V. Pavlova, I. L. Voronova, S. M. Chohlunov | ||
| "... .8% of patients also received combination of clopidogrel and acetylsalicylic acid, but changed medicinal products ..." | ||
| Vol 7, No 3 (2011) | VALUE OF NICOTINIC ACID IN THE CURRENT CARDIOLOGY | Abstract similar documents |
| E. P. Trukhacheva, M. V. Ezhov | ||
| "... acid intake in these patients may be necessary for the normalization of lipid profile, including ..." | ||
| Vol 18, No 1 (2022) | The Impact of Combination Therapy with Rivaroxaban and Acetylsalicylic Acid in Patients with Coronary Heart Disease on the Achievement of the Target for Reducing Mortality from Cardiovascular Diseases of the Federal Project "Fight against Cardiovascular Diseases" | Abstract similar documents |
| M. V. Zhuravleva, A. V. Panov, A. R. Kuksenok | ||
| "... Aim. To assess the outcomes of combination therapy with rivaroxaban and acetylsalicylic acid (ASA ..." | ||
| Vol 18, No 6 (2022) | The Pathogenetic Basis of the Action of Bempedoic Acid | Abstract similar documents |
| A. S. Petrosyan, R. S. Rud', P. P. Polyakov, A. Kh. Kade, S. A. Zanin | ||
| "... acid, which can have a positive effect on a number of endpoints as the results of third phase trials ..." | ||
| Vol 5, No 6 (2009) | STATINS AND URSODEOXYCHOLIC ACID: COOPERATION OR NEUTRALITY? | Abstract similar documents |
| I. N. Grigorieva, Y. M. Pozdnyakov | ||
| "... acid (UDCA) are analyzed. In GSD statin therapy was often accompanied with reduction of bile ..." | ||
| Vol 19, No 3 (2023) | Association of polymorphic variants of CYP2C19, P2RY12, ITGB3, ITGA2 and eNOS3 genes with high residual platelet reactivity while taking clopidogrel and acetylsalicylic acid at different terms of myocardial infarction | Abstract similar documents |
| T. P. Pronko, V. A. Snezhitskiy, T. L. Stepuro, A. V. Kapytski | ||
| "... and acetylsalicylic acid (ASA) at different terms of myocardial infarction (MI). Material and methods. The study ..." | ||
| Vol 13, No 4 (2017) | PROLONGED DUAL ANTIPLATELET THERAPY AFTER MYOCARDIAL INFARCTION: WHAT THE RESULTS OF THE PEGASUS-TIMI 54 TRIAL SHOW | Abstract similar documents |
| I. S. Yavelov | ||
| "... and safety of prolonged use of a combination of acetylsalicylic acid and blocker P2Y12 platelet receptor ..." | ||
| Vol 8, No 4 (2012) | THE RISK OF BLEEDINGS IN PATIENTS WITH ATRIAL FIBRILLATION DURING ANTICOAGULANT THERAPY | Abstract similar documents |
| M. Yu. Gilyarov | ||
| "... . Along with traditional drugs (acetylsalicylic acid, warfarin) rivaroxaban is specially considered ..." | ||
| Vol 18, No 4 (2022) | Uric Acid as a Risk Factor for Cardiovascular Diseases | Abstract similar documents |
| A. S. Safaryan, A. S. Lishuta, D. V. Nebieridze | ||
| "... and more attention. The article talks about the role of uric acid in the body, the reasons for its increase ..." | ||
| Vol 7, No 5 (2011) | DIETARY FATTY ACIDS. EFFECTS ON THE RISK OF CARDIOVASCULAR DISEASES | Abstract similar documents |
| N. V. Perova, V. A. Metel'skaya, E. I. Sokolov, G. N. Shchukina, V. M. Fomina | ||
| "... The world publications data about the impact of consumption and the fatty acids ratio in consumed ..." | ||
| Vol 6, No 3 (2010) | CLINICAL SIGNIFICANCE OF ANEMIC SYNDROME IN PATIENTS WITH CHRONIC HEART FAILURE | Abstract similar documents |
| V. N. Larina, B. Ya. Bart, V. G. Larin | ||
| "... , vitamin B12 or folic emacid/em was a reason of anemia in 35,8%, 9,4% and 15,1% of patients, respectively ..." | ||
| Vol 14, No 2 (2018) | DOCTOR’S ADHERENCE TO RECOMMENDATIONS GOVERNING THE ANTIPLATELET AGENTS USE IN THE CARDIOVASCULAR DISEASES PREVENTION AND TREATMENT | Abstract similar documents |
| N. В. Perepech, A. V. Tregubov | ||
| "... . The results of the study reflect the doctor’s tendency to use emacetylsalicylic/em emacid/em for the primary prevention ..." | ||
| Vol 8, No 1 (2012) | NEW POSSIBILITIES IN HEART FAILURE THERAPY: POTENTIAL OF DRUGS BASED ON URSODEOXYCHOLIC ACID | Abstract similar documents |
| O. M. Drapkina, O. N. Korneyeva | ||
| Vol 4, No 5 (2008) | MOLECULAR MECHANISMS OF ACTION OF MAGNESIUM OROTATE ON CARDIOVASCULAR SYSTEM | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova | ||
| "... Orotic emacid/em is one of the intermediates in the pyrimidine biosynthesis. Mechanisms of physiological ..." | ||
| Vol 11, No 1 (2015) | PHARMACOECONOMIC ASPECTS OF APIXABAN FOR PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION | Abstract similar documents |
| A. V. Rudakova | ||
| "... (warfarin), antiplatelet therapy (emacetylsalicylic/em emacid/em) and novel oral anticoagulants such as apixaban ..." | ||
| Vol 8, No 2 (2012) | CLINICAL IMPLICATION OF FATTY ACID CHANGES IN PATIENTS WITH PRIMARY GOUT ASSOCIATED WITH ARTERIAL HYPERTENSION | Abstract similar documents |
| N. N. Kushnarenko, A. V. Govorin | ||
| "... Aim. To study blood levels of non-esterified fatty emacids/em (NEFAs) and adenyl nucleotides, and fatty ..." | ||
| Vol 2, No 1 (2006) | THE USE OF A NEW APPROACH TO PREVENTION AND THERAPY OF ACUTE ARTERIAL HYPERTENSION WITH COMPLEX OF WELL-KNOWN DRUGS WITH VEGETABLE GLYCOSIDES (EXPERIMENTAL STUDY) | Abstract similar documents |
| T. G. Tolstikova, I. V. Sorokina, A. O. Brisgalov, M. P. Dolgich, G. I. Lifshitz, M. V. Chvostov | ||
| "... short acting formulation while NC is a new formulation of nifedipine in complex with glycyrrhizic emacid/em ..." | ||
| Vol 9, No 1 (2013) | THE USE OF OMEGA-3 FATTY ACIDS FOR THE TREATMENT OF PATIENTS WITH CARDIAC ARRHYTHMIAS | Abstract similar documents |
| A. O. Malygin, V. L. Doshchitsin | ||
| "... Antiarrhythmic effect of omega-3 polyunsaturated fatty emacids/em (ω-3 PUFA), eicosapentaenoic ..." | ||
| Vol 8, No 1 (2012) | OMEGA-3 POLYUNSATURATED FATTY ACIDS IN THE TREATMENT OF PATIENTS WITH CARDIOVASCULAR DISEASES | Abstract similar documents |
| A. V. Govorin, A. P. Filev | ||
| "... For today there are convincing evidences of beneficial effect of ω-3 polyunsaturated fatty emacids/em ..." | ||
| Vol 11, No 3 (2015) | OMEGA-3 FATTY ACIDS AND AGE-RELATED DISEASES: REALITIES AND PROSPECTS | Abstract similar documents |
| O. M. Drapkina, R. N. Shepel' | ||
| "... Efficacy of omega-3 fatty emacids/em in cardiology is so high that in many countries omega-3 fatty ..." | ||
| Vol 16, No 3 (2020) | The Value of Omega-3 Fatty Acids in the Prevention of Heart Rhythm Disorders | Abstract similar documents |
| V. I. Podzolkov, A. I. Tarzimanova | ||
| "... One of the trends in modern cardiology is the use of omega-3 polyunsaturated fatty emacids/em (ω-3 PUFA ..." | ||
| Vol 18, No 2 (2022) | Antiarrhythmic and Hemodynamic Effects of Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Diseases | Abstract similar documents |
| A. N. Zakirova, N. E. Zakirova | ||
| "... and clinical studies indicating the use of ω-3 PUFA (polyunsaturated fatty emacids/em) contributes to reduce ..." | ||
| Vol 8, No 1 (2012) | URSODEOXYCHOLIC ACID IN PATIENTS WITH CHRONIC HEART FAILURE. A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, CROSSOVER TRIAL | similar documents |
| S. von Haehling, J. C. Schefold, E. A. Jankowska, J. Springer, A. Vazir, P. R. Kalra, A. Sandek, G. Fauler, T. Stojakovic, M. Trauner, P. Ponikowski, H-D. Volk, W. Doehner, A. J. S. Coats, P. A. Poole-Wilson, S. D. Anker | ||
| "... Цель. Оценить влияние урсодеоксихолевой emкислоты/em (УДХК) на функцию эндотелия и маркеры воспаления у ..." | ||
| Vol 18, No 4 (2022) | Detection and Treatment of Hyperuricemia in Clinical Practice (According to the PROFILE Outpatient Registry) | Abstract similar documents |
| N. P. Kutishenko, S. Yu. Martsevich, A. V. Zagrebelnyy, Yu. V. Lukina, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, S. N. Tolpygina, S. V. Blagodatskikh, I. V. Budaeva, E. S. Nekoshnova, O. M. Drapkina | ||
| "... cardiovascular risk and the frequency of prescribing drugs that lower serum uric emacid/em (sUA) levels in real ..." | ||
| Vol 12, No 3 (2016) | MEMBRANE BILE ACID RECEPTOR TGR5 - A NEW TARGET IN THE STUDY OF METABOLIC, INFLAMMATORY AND NEOPLASTIC DISEASES | Abstract PDF (Eng) similar documents |
| O. M. Drapkina, E. I. Fomicheva | ||
| "... TGR5 are G-protein-linked, membrane bile emacids/em receptors that widely express in tissues of animals ..." | ||
| Vol 7, No 5 (2011) | HOMOCYSTEINE-LOWERING THERAPY AND LONG-TERM PROGNOSIS AFTER ELECTIVE PERCUTANEOUS CORONARY INTERVENTION | Abstract similar documents |
| O. O. Shakhmatova, A. L. Komarov, A. N. Samko, T. I. Kotkina, D. V. Rebrikov, A. D. Deev, E. P. Panchenko | ||
| "... Background. Vitamins В6 В12 and folic emacid/em (FA) therapy to reduce cardiovascular risk appears ..." | ||
| Vol 17, No 6 (2021) | Hyperuricemia: Features of the Diet | Abstract similar documents |
| O. B. Shvabskaia, O. V. Izmailova, N. S. Karamnova, O. M. Drapkina | ||
| "... habits, individual foods and nutrients on serum uric emacid/em (SUA) levels and the risk of developing HU ..." | ||
| Vol 7, No 1 (2011) | USE OF N-3 POLYUNSATURATED FATTY ACIDS 90% (OMACOR) FOR THERAPY AND PREVENTION OF CARDIO-VASCULAR DISEASES | similar documents |
| Vol 2, No 3 (2006) | NEW EVIDENCES OF POSSIBILITY OF OMEGA-3 ACIDS USE FOR MYOCARDIAL INFARCTION SECONDARY PREVENTION | Abstract similar documents |
| A. I. Martinov, V. L. Chomenko | ||
| "... fatty emacids/em (PUFAs) were analyzed. It was proved that PUFAs class omega-3 have positive effects ..." | ||
| Vol 4, No 3 (2008) | OMEGA-3 POLYUNSATURATED FATTY ACIDS IN ATRIAL FIBRILLATION PREVENTION AFTER SURGICAL MYOCARDIAL REVASCULARIZATION | Abstract similar documents |
| A. V. Panov, B. A. Tatarskiy, M. L. Gordeev, R. I. Nilk | ||
| "... Aim. To estimate an efficacy of therapy with ω-3 polyunsaturated fatty emacids/em (PUFA) in patients ..." | ||
| Vol 8, No 3 (2012) | THE EFFICACY OF COMBINED BIOMARKER TESTS IN EARLY DIAGNOSTICS OF ACUTE MYOCARDIAL INFARCTION AFTER CLINICAL SYMPTOMS ONSET: ROLE OF HEART-TYPE FATTY ACID-BINDING PROTEIN | Abstract similar documents |
| O. V. Baturina, S. R. Gilyarevsky, I. M. Kuzmina, M. A. Godkov, E. V. Klychnikova | ||
| "... Aim. To evaluate the diagnostic value of heart-type fatty emacid/em-binding protein (H-FABP ..." | ||
| Vol 18, No 1 (2022) | Omega-3 Polyunsaturated Fatty Acids: the Role in Prevention of Atrial Fibrillation in Patients with Coronary Artery Disease after Coronary Artery Bypass Graft Surgery | Abstract PDF (Eng) similar documents |
| O. A. Rubanenko, Yu. V. Shchukin, L. V. Limareva, T. K. Ryazanova, A. O. Rubanenko, I. L. Davydkin | ||
| "... Aim. To estimate the role of omega-3 polyunsaturated fatty emacids/em (PUFAs) administration in atrial ..." | ||
| Vol 7, No 2 (2011) | EFFECTS OF N-3 POLYUNSATURATED FATTY ACIDS ON LEFT VENTRICULAR FUNCTION AND FUNCTIONAL CAPACITY IN PATIENTS WITH DILATED CARDIOMYOPATHY | Abstract similar documents |
| S. Nodari, M. Triggiani, U. Campia, A. Manerba, G. Milesi, B. M. Cesana, M. Gheorghiade, L. Dei Cas | ||
| "... Цель. Оценить влияния n-3 полиненасыщенных жирных emкислот/em (ПНЖК) на систолическую функцию левого ..." | ||
| Vol 10, No 2 (2014) | HYPERURICEMIA AND ITS CORRELATES IN THE RUSSIAN POPULATION (RESULTS OF ESSE-RF EPIDEMIOLOGICAL STUDY) | Abstract similar documents |
| S. A. Shalnova, A. D. Deev, G. V. Artamonov, D. V. Duplyakov, A. Yu. Efanov, Yu. V. Zhernakova, A. O. Konradi, R. A. Libis, G. A. Muromtseva, S. V. Nedogoda, E. V. Oschepkova, S. V. Romanchuk, O. P. Rotar, V. N. Titov, Z. A. Toguzova, I. A. Trubacheva, G. I. Furmenko, E. V. Shlyakhto, S. A. Boytsov | ||
| "... этих регионах существует наименьшая распространенность повышенного уровня мочевой emкислоты/em ..." | ||
| Vol 11, No 2 (2015) | CLINICAL CASE HISTORY OF EPTIFIBATIDE USE DURING CORONARY INTERVENTION IN PATIENT WITH CORONARY FAILURE | Abstract similar documents |
| K. A. Kireev, A. V. Krasnopeev, T. S. Kireeva | ||
| "... antiplatelet drugs (emacetylsalicylic/em emacid/em and clopidogrel) and heparin. There were not any reasons ..." | ||
| Vol 16, No 4 (2020) | Cardiovascular Comorbidity: Patient with Coronary Artery Disease and Peripheral Artery Atherosclerosis. How to Identify and Manage the Risks of Ischemic Events? | Abstract similar documents |
| O. L. Barbarash, V. V. Kashtalap, I. A. Shibanova | ||
| "... and the antiplatelet agent – emacetylsalicylic/em emacid/em, are highlighted on the basis of the results of clinical studies ..." | ||
| Vol 13, No 1 (2017) | SCHEME FOR COMBINED USE OF STATINS AND URSODEOXYCHOLIC ACID IN PATIENTS WITH A HIGH RISK OF CARDIOVASCULAR EVENTS AND CONCOMITANT NON-ALCOHOLIC FATTY LIVER DISEASE: PROBLEMS OF PRACTICAL APPLICATION | Abstract similar documents |
| S. N. Bel'diev | ||
| "... of statins and ursodeoxycholic emacid/em (UDCA) co-administration was developed in 2014 and subsequently in 2016 ..." | ||
| Vol 10, No 2 (2014) | STUDY OF URSODEOXYCHOLIC ACID INFLUENCE ON EFFICACY AND SAFETY OF STATIN THERAPY IN PATIENTS WITH DISEASES OF THE LIVER, GALL BLADDER AND/OR BILIARY TRACT (THE RAKURS STUDY) | Abstract similar documents |
| S. Yu. Martsevich, N. P. Kutishenko, L. Yu. Drozdova, O. V. Lerman, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yahontov | ||
| "... Aim. To assess the potential of ursodeoxycholic emacid/em (UDCA) in the prevention of liver dysfunction ..." | ||
| Vol 20, No 2 (2024) | Comparative placebo-controlled study on the effect of dietary supplements containing omega-3 polyunsaturated fatty acids on hemodynamics and lipid metabolism in postmenopausal women | Abstract similar documents |
| D. A. Napalkov, A. A. Sokolova, A. A. Kudrjavtseva, A. I. Skripka, A. V. Zhilenko, E. V. Kolpachkova, D. K. Varvarina | ||
| "... Aim. To study the effect of dietary supplements containing omega-3 polyunsaturated fatty emacids/em ..." | ||
| Vol 12, No 3 (2016) | THE PROBLEM OF STATIN USE IN PATIENTS WITH CARDIOVASCULAR DISEASES AND CONCOMITANT LIVER DISEASES. WHAT PREVENTS OVERCOMING STATINOPHOBIA? | Abstract PDF (Eng) similar documents |
| S. N. Bel'diev | ||
| "... and ursodeoxycholic emacid/em; 4) view of the inadmissibility of statin use in patients with transaminase levels more than ..." | ||
| Vol 16, No 2 (2020) | Gut Microbiota Composition and Metabolites as the new Determinants of Cardiovascular Pathology Development | Abstract similar documents |
| O. M. Drapkina, A. N. Kaburova | ||
| "... (TMAO), short chain fatty emacids/em (SCFA) and secondary bile emacids/em. TMAO is known due to its role ..." | ||
| Vol 8, No 2 (2012) | THE "NEW" DRUG CLASSES IN THE TREATMENT OF CHRONIC HEART FAILURE AND THEIR EVIDENCE BASE | Abstract similar documents |
| S. N. Tereshchenko, I. V. Zhirov, A. G. Kochetov, O. V. Uspenskaya | ||
| "... A comparison of ivabradine and omega-3 polyunsaturated fatty emacids/em, drugs with principally ..." | ||
| Vol 15, No 2 (2019) | Correction of Hypertriglyceridemia as the Way to Reduce Residual Risk in Diseases Caused by Atherosclerosis. Conclusion of the Advisory Board of the Russian Society of Cardiology, the Russian Scientific Medical Society of Therapists, the Eurasian Association of Therapists, the Russian National Atherosclerosis Society, the Russian Association of Endocrinologists, and the National League of Cardiologic Genetics | Abstract similar documents |
| G. P. Arutyunov, S. A. Boytsov, M. I. Voyevoda, V. S. Gurevich, O. M. Drapkina, V. V. Kukharchuk, A. I. Martynov, I. V. Sergiyenko, M. V. Shestakova, A. S. Aliyeva, N. M. Akhmedzhanov, M. G. Bubnova, А. S. Galyavich, I. G. Gordeyev, M. V. Ezhov, Yu. A. Karpov, V. O. Konstantinov, S. V. Nedogoda, E. M. Nifontov, Ya. A. Orlova, A. V. Panov, S. A. Sayganov, V. V. Skibitskiy, E. I. Tarlovskaya, S. A. Urazgildeyeva, Yu. Sh. Khalimov | ||
| "... polyunsaturated fatty emacid/em can be used in the dosage of 2-4 g daily. In patients with triglyceride level higher ..." | ||
| Vol 17, No 5 (2021) | Impact of Gut Microbiota on the Risk of Cardiometabolic Diseases Development | Abstract similar documents |
| L. E. Vasilyeva, O. M. Drapkina | ||
| Vol 19, No 3 (2023) | Nutraceutical support in the prevention and treatment of cardiovascular diseases | Abstract similar documents |
| E. V. Gracheva, E. A. Starovoytova, E. S. Kulikov, N. A. Kirillova, S. V. Fedosenko, M. A. Balaganskaya, D. V. Kromka | ||
| "... the short-term effects of taking omega-3 polyunsaturated fatty emacids/em (effect on the blood lipid spectrum ..." | ||
| Vol 7, No 2 (2011) | COMMENTS TO THE PAPER S. NODARI ET AL. «EFFECTS OF N-3 POLYUNSATURATED FATTY ACIDS ON LEFT VENTRICULAR FUNCTION AND FUNCTIONAL CAPACITY IN PATIENTS WITH DILATED CARDIOMYOPATHY» | similar documents |
| S. N. Tereshchenko | ||
| Vol 11, No 3 (2015) | THE IMPROVEMENT OF LIPID-LOWERING THERAPY EFFECTIVENESS IN PATIENTS WITH HIGH CARDIOVASCULAR RISK AND CONCOMITANT LIVER DISEASE (RESULTS OF ADDITIONAL ANALYSIS OF THE RAKURS STUDY) | Abstract similar documents |
| N. P. Kutishenko, S. Yu. Martsevich, O. V. Lerman, I. S. Balashov, V. A. Nevzorova, I. I. Reznik, G. V. Shavkuta, D. A. Yakhontov | ||
| "... Aim. To evaluate the differences between a group of patients treated with ursodeoxycholic emacid/em ..." | ||
| Vol 9, No 2 (2013) | TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER. (Part 1) | Abstract similar documents |
| S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich | ||
| "... increased from 20% to 84.4%, statins - from 10% to 85.5%, β-blockers - from 20% to 91%, emacetylsalicylic/em emacid/em ..." | ||
| Vol 2, No 4 (2006) | THROMBOLYTIC THERAPY IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION | Abstract similar documents |
| E. V. Konstantinova, A. V. Magnitskyi, N. A. Schostak | ||
| "... and safety of fibrinolytics by their combination with emacetylsalicylic/em emacid/em, IIb/IIIa receptor inhibitors ..." | ||
| Vol 7, No 4 (2011) | EXPERT CONSENSUS ON ETHYL ETHER OF ω-3 POLYUNSATURATED FATTY ACIDS 90% FOR THERAPY AND PREVENTION OF CHRONIC HEART FAILURE EXECUTIVE SUMMARY OF EXPERT COUNCIL, JUNE 2011 | similar documents |
| Vol 8, No 3 (2012) | MAGNESIUM-CONTAINING DRUGS IN CARDIOVASCULAR DISEASES | Abstract similar documents |
| A. V. Govorin, A. P. Filev | ||
| "... intracellular penetration. Magnerot deserves attention as a complex drug consisting of magnesium and orotic emacid/em ..." | ||
| Vol 13, No 5 (2017) | INFLUENCE OF SWITCHING OF CLOPIDOGREL TO TICAGRELOR ON THE DEVELOPMENT OF CARDIOVASCULAR EVENTS IN PATIENTS WITH ST SEGMENT ELEVATION | Abstract similar documents |
| E. V. Tavlueva, A. V. Alekseenko, O. V. Gruzdeva, O. L. Barbarash | ||
| "... doses of emacetylsalicylic/em emacid/em (250 mg) and clopidogrel (600 mg). After 12-24 hours, the patients were ..." | ||
| Vol 13, No 1 (2017) | ANTIPLATELET THERAPY OF ATRIAL FIBRILLATION: FOCUS ON THE ELDERLY | Abstract similar documents |
| E. А. Ushkalova, S. K. Zyryanov, E. V. Dumchenko | ||
| "... that risk associated with emacetylsalicylic/em emacid/em (ASA) use in patients ≥75 years can overweigh its potential ..." | ||
| Vol 15, No 6 (2019) | New Opportunities for Improving the Prognosis of Patients with Chronic Ischemic Heart Disease | Abstract similar documents |
| N. B. Perepech | ||
| "... and emacetylsalicylic/em emacid/em on the prognosis of patients with chronic IHD or peripheral artery disease, are presented ..." | ||
| Vol 9, No 3 (2013) | PROBLEMS AND PROSPECTS OF INTERMEDIARY METABOLISM CORRECTION IN PATIENTS WITH VASCULAR COMORBIDITY | Abstract similar documents |
| S. A. Rumyantseva, R. G. Oganov, V. A. Stupin, E. V. Silina, A. S. Orlova, S. B. Bolevich, V. V. Afanasev, E. N. Kabaeva, S. A. Volik | ||
| "... Disorders of intermediary metabolism in the glycolysis cycles and fatty emacids/em oxidation play ..." | ||
| Vol 8, No 4 (2012) | COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART I) | Abstract similar documents |
| S. Y. Martsevich, S. N. Tolpygina | ||
| "... demonstrated significant reduction in fasting plasma glucose level (-0.45±1.2 mM/l, p=0.01), uric emacid/em (-0.05±0 ..." | ||
| Vol 7, No 4 (2011) | FOCUS ON MAGNESIUM BASED DRUGS | Abstract similar documents |
| I. I. Esenova | ||
| "... deficiency, advantages of magnesium salts of orotic emacid/em are reviewed. ..." | ||
| Vol 10, No 6 (2014) | PHARMACOEPIDEMIOLOGIC ANALYSIS OF HOSPITAL TREATMENT OF PATIENTS WITH CEREBRAL INFARCTION AND ATRIAL FIBRILLATION | Abstract similar documents |
| N. V. Mikheeva, O. V. Reshetko, N. V. Furman | ||
| "... .12.2011. Results. emAcetylsalicylic/em emacid/em was prescribed to 66.7% of patients, warfarin – 3.9%. At that target level ..." | ||
| Vol 8, No 1 (2012) | RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION | Abstract similar documents |
| V. A. Sulimov, E. V. Moroz | ||
| "... Aim. To study prevalence of resistance to emacetylsalicylic/em emacid/em, clopidogrel and dual resistance ..." | ||
| Vol 14, No 2 (2018) | FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
| S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova | ||
| "... of recommendations of emacetylsalicylic/em emacid/em as monotherapy (down to 93.0%) and increased – in combination ..." | ||
| Vol 13, No 2 (2017) | SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY) | Abstract similar documents |
| S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, D. A. Dimitrova | ||
| "... prescriptions was revealed (at the second stage of the study emacetylsalicylic/em emacid/em 100 mg/day received 75 ..." | ||
| Vol 14, No 1 (2018) | COMORBID PATIENT IN GASTROENTEROLOGY: INDIVIDUAL APPROACH | Abstract similar documents |
| I. G. Bakulin, S. A. Sayganov, M. I. Skalinskaya, E. V. Skazyayeva, I. V. Lapinskii | ||
| "... cardiovascular risk taking emacetylsalicylic/em emacid/em and having a high risk of gastrointestinal tract bleeding ..." | ||
| Vol 7, No 6 (2011) | PHARMACOTHERAPY ANALYSIS OF ACUTE ST-ELEVATION MYOCARDIAL INFARCTION IN HOSPITALS OF VARIOUS TYPES | Abstract similar documents |
| R. M. Magdeev, O. V. Reshetko, E. Y. Rudnichenko, N. V. Furman, P. V. Dolotovskaya, T. Y. Grozdova, L. N. Volkova | ||
| "... %, respectively). In MH dipyridamole was used in 9.6% of patients as an alternative to the emacetylsalicylic/em emacid/em ..." | ||
| Vol 7, No 6 (2011) | CORONARY EMBOLISM WITH FRAGMENTED THROMBUS FROM THE LEFT VENTRICLE IN PATIENT WITH POSTINFARCTION ANEURYSM | Abstract similar documents |
| Yu. F. Salakhova, S. V. Gar'kina, T. V. Kislukhin, D. V. Duplyakov, V. S. Ivanov, E. R. Perunova, E. I. Bazhenova, S. E. Burnazyan, S. M. Khokhlunov | ||
| "... therapy (emacetylsalicylic/em emacid/em, clopidogrel, warfarin) was made on the 4th day of disease onset taking ..." | ||
| 1 - 100 of 309 Items | 1 2 3 4 > >> | |
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
